Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Details about COVID-19, monkeypox, and the flu vaccine

Long-term survival after two surgical resections of peritoneal metastases from hepatocellular carcinoma with an interval of 4 years CLINICAL CASE REPORTS Kitajima, T., Hashimoto, M., Sasaki, K., Matsuda, M., Kuroda, Y., Fujii, T., Watanabe, G. 2014; 2 (2): 37-41

Abstract

We propose that surgical resections of peritoneal metastases arising from hepatocellular carcinoma are an option for selected patients with controlled HCC in the liver, and without metastases in other organs, when the complete removal of such metastases can be achieved, especially in the case of patients with normal liver function.

View details for DOI 10.1002/ccr3.50

View details for Web of Science ID 000217130000004

View details for PubMedID 25356240

View details for PubMedCentralID PMC4184626